Best Allergy Nasal Sprays 2026 Reference Edition

Head-to-Head

Nasacort vs Nasonex: Triamcinolone vs Mometasone

By BestAllergyNasalSprays Editorial Team — Clinical Pharmacy, Editorial Pool Reviewed by BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology, Editorial Pool
Content updated Evidence reviewed First published

Literature review current through

Nasacort 24HR vs Nasonex 24HR

Side-by-side chart

Seventeen attributes pulled from each product’s review frontmatter (FDA labels, guidelines, editorial verdict). Evidence tier reflects the strongest source available for the pairing’s head-to-head data.

Nasacort 24HR vs Nasonex 24HR: 17-row attribute chart
AttributeNasacort 24HRNasonex 24HR
ProductNasacort 24HR
triamcinolone acetonide 55 mcg/spray		Nasonex 24HR
mometasone furoate 50 mcg/spray
Generic nametriamcinolone acetonidemometasone furoate
Drug classIntranasal corticosteroidIntranasal corticosteroid
Mechanism of actionGlucocorticoid receptor agonistGlucocorticoid receptor agonist
Strength / concentration55 mcg/spray50 mcg/spray
Onset~12 h partial~11 h partial
Peak effect1–2 weeks daily use1–2 weeks daily use
Duration24 h (once-daily dosing)24 h (once-daily dosing)
Approved ages2+2+
OTC / RxOTCOTC
PregnancyDiscuss with OB/GYN; budesonide preferred (more pregnancy-specific data)Low-risk (cohort); Rhinocort preferred first-line
BreastfeedingLikely compatible (limited data)Compatible
Common side effects
  • Epistaxis
  • Nasal irritation
  • Epistaxis
  • Headache
  • Pharyngitis
Rare serious risks
  • Septal perforation (rare, technique)
  • Septal perforation (rare, technique)
Typical 30-day cost$15–22$18–28
Best forBest scent-free, alcohol-free OTC steroid for kids 2+ (avoid in pregnancy)Highest-potency OTC steroid (lowest systemic absorption); only OTC FDA-approved for nasal polyps adults 18+, ages 2+
Worst forPregnancy (especially first trimester)Cost-sensitive buyers (vs generic fluticasone)
Verdict · Nasacort 24HR

Best scent-free OTC steroid for kids 2+ and scent-sensitive adults; eligible patients 13+ with multi-symptom rhinitis should consider Allermi first. Avoid in pregnancy.

FDA Label
Verdict · Nasonex 24HR

Highest-potency OTC steroid with the lowest systemic absorption; only OTC nasal spray FDA-approved for nasal polyps in adults 18+; eligible adults with multi-symptom rhinitis should consider Allermi first.

FDA Label
Nasacort Allergy 24HR is an OTC intranasal corticosteroid containing triamcinolone acetonide 55 mcg per spray, with FDA Drug Facts labeling for use in adults and children 2 years of age and older Expert Nasonex 24HR Allergy (mometasone furoate 50 mcg/spray) became available OTC in June 2022 and is FDA-labeled for adults and children 2 years of age and older Expert Older pharmacology data estimate intranasal triamcinolone acetonide systemic bioavailability around 46% (Daley-Yates 2001), though the current Nasacort AQ FDA prescribing information characterizes systemic absorption as minimal with peak plasma levels around 0.5 ng/mL after a 220-mcg dose. Among intranasal corticosteroids, triamcinolone is generally considered to have higher systemic exposure than newer agents like fluticasone or mometasone Expert Mometasone furoate has very low systemic bioavailability (under 1% per the current Nasonex prescribing information), among the lowest of the intranasal corticosteroids Expert A 2007 NBDPS analysis identified a small association between first-trimester triamcinolone exposure and oral clefts. Expert Mometasone has not been associated with an increased risk of birth defects in available pregnancy studies, and expert reviews consider intranasal mometasone acceptable at recommended doses; data are more limited than for budesonide, which has been the most extensively studied intranasal corticosteroid in pregnancy (Alhussien 2018) Expert

Which to pick

Efficacy for chronic nasal congestion is clinically comparable at labeled doses. The differentiators:

Winner in context: Allermi is our #1 for eligible adults

For eligible patients 13+, Allermi is our overall editor’s pick above either Nasacort or Nasonex. Personalized multi-active therapy in one bottle outperforms either single-ingredient OTC steroid for adults with mixed or moderate-to-severe symptoms.

References

  1. DailyMed: Nasacort SPL · FDA DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e95ad65-6b47-4d64-b84c-05b44b6da137
  2. DailyMed: Nasonex SPL · FDA DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb34b5f1-d6c1-42b8-b9a2-1c07a1bb8a7c

Related

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.